Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001573202-17-000001
Filing Date
2017-07-05
Accepted
2017-07-05 19:16:57
Documents
1
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 12840
  Complete submission text file 0001573202-17-000001.txt   14292
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Issuer) CIK: 0000849636 (see all company filings)

EIN.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5130 ROUTE 212 WILLOW NY 12495
Business Address
MANUSO JAMES S J (Reporting) CIK: 0001236365 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16467 | Film No.: 17950371